Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells-Reference-Cited by-同舟云学术

Profiling of circulating tumor DNA in plasma of non‐small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells

Published:2019-05-21 Issue:8 Volume:8 Page:3685-3697
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Garcia Jessica¹²³⁴,Wozny Anne‐Sophie¹³,Geiguer Florence¹³⁴,Delherme Aurélia¹³⁴,Barthelemy David¹²³⁴,Merle Patrick⁵,Tissot Claire⁶,Jones Frederick S.⁷,Johnson Chassidy⁸,Xing Xiaobin⁹,Xu Zhenyu⁹,Edelstein Daniel L.⁷,Brevet Marie²³¹⁰,Souquet Pierre‐Jean¹¹,Rodriguez‐Lafrasse Claire¹¹²,Payen Léa¹²³⁴^ORCID,Couraud Sébastien³¹¹¹³

Affiliation:

1. Laboratoire de Biochimie et Biologie Moléculaire, Groupe Hospitalier Sud Hospices Civils de Lyon Lyon France

2. Cancer Research Center of Lyon, INSERM U1052, CNRS UMR5286 Claude Bernard University, University of Lyon Lyon France

3. CIRculating CANcer (CIRCAN) program Hospices Civils de Lyon Cancer institute Lyon France

4. Laboratoire Commun de Recherche Hospices Civils de Lyon – BioMérieux, Centre Hospitalier Lyon Sud Hospices Civils de Lyon Lyon France

5. Service de Pneumologie et oncologie thoracique CHU G Montpied Clermont‐Ferrand France

6. Service de Pneumologie et Cancérologie Thoracique CHU Saint Etienne Saint‐Priest‐en‐Jarez France

7. Medical Scientific Affairs Sysmex Inostics, GmBH Hamburg Germany

8. Biolidics Limited Singapore Singapore

9. SOPHiA GENETICS SA, Headquarters Saint Sulpice Switzerland

10. Institut de pathologie multisites des HCL‐Site Est, Hospices Civils de Lyon Lyon France

11. Service de Pneumologie aigue spécialisée et cancérologie thoracique Groupement hospitalier sud, Institut de Cancérologie des Hospices Civils de Lyon Lyon France

12. UMR CNRS 5822/IN2P3, IPNL, PRISME, Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon‐Sud Université Lyon 1 Lyon France

13. EMR 3738 Ciblage Thérapeutique en Oncologie, Faculté de médecine Lyon Sud Université Lyon 1, Université de Lyon Lyon France

Funder

AstraZeneca

Ligue Contre le Cancer

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2244

Reference46 articles.

1. Oncogenic driver mutations in lung cancer